Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 617

1.

Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR.

Lancet Oncol. 2006 Dec;7(12):983-90.

PMID:
17138219
2.

Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.

Breast J. 2004 Mar-Apr;10(2):101-5.

PMID:
15009035
3.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
4.

Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).

Eldweny H, Alkhaldy K, Alsaleh N, Abdulsamad M, Abbas A, Hamad A, Mounib S, Essam T, Kukawski P, Bobin JY, Oteifa M, Amanguono H, Abulhoda F, Usmani S, Elbasmy A.

J Egypt Natl Canc Inst. 2012 Mar;24(1):23-30. doi: 10.1016/j.jnci.2011.12.004. Epub 2012 Jan 23.

5.

Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.

Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N.

Int J Surg Pathol. 2010 Feb;18(1):36-41. doi: 10.1177/1066896909332113. Epub 2009 May 15.

PMID:
19448065
6.

Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.

Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA.

Eur J Surg Oncol. 2009 Feb;35(2):159-63. doi: 10.1016/j.ejso.2008.07.017. Epub 2008 Sep 11.

PMID:
18789841
7.

Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.

Takei H, Kurosumi M, Yoshida T, Ishikawa Y, Hayashi Y, Ninomiya J, Tozuka K, Oba H, Inoue K, Nagai S, Saito Y, Kazumoto T, Saitoh J, Tabei T.

Breast Cancer. 2010;17(1):9-16. doi: 10.1007/s12282-009-0154-4. Epub 2009 Aug 22.

PMID:
19701679
8.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
9.

Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.

Geertsema D, Gobardhan PD, Madsen EV, Albregts M, van Gorp J, de Hooge P, van Dalen T.

Ann Surg Oncol. 2010 Oct;17(10):2690-5. doi: 10.1245/s10434-010-1052-x. Epub 2010 Apr 27.

10.

Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.

Pernas S, Gil M, Benítez A, Bajen MT, Climent F, Pla MJ, Benito E, Guma A, Gutierrez C, Pisa A, Urruticoechea A, Pérez J, Gil Gil M.

Ann Surg Oncol. 2010 Mar;17(3):772-7.

PMID:
20183912
11.
12.

Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.

Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.

Ann Surg Oncol. 2010 Feb;17(2):552-7. doi: 10.1245/s10434-009-0800-2.

PMID:
19957043
13.

200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up.

Reitsamer R, Peintinger F, Prokop E, Rettenbacher L, Menzel C.

Br J Cancer. 2004 Apr 19;90(8):1551-4.

14.

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9. Epub 2009 Sep 4.

PMID:
19760047
15.

A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.

Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, Renier M, Racano C, Carraro P, Nitti D; GIVOM Trialists..

Ann Surg. 2008 Feb;247(2):207-13. doi: 10.1097/SLA.0b013e31812e6a73.

PMID:
18216523
16.

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.

Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK.

Cancer. 2007 Apr 1;109(7):1255-63.

17.

Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.

Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L.

Eur J Surg Oncol. 2003 Apr;29(3):221-3.

PMID:
12657230
18.

Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.

Chung MH, Ye W, Giuliano AE.

Ann Surg Oncol. 2001 Oct;8(9):688-92.

PMID:
11597008
19.

Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.

Goyal A, Newcombe RG, Chhabra A, Mansel RE.

Ann Surg Oncol. 2008 Jan;15(1):262-7. Epub 2007 Sep 19.

PMID:
17879117

Supplemental Content

Support Center